ASIT Biotech SA (EUR)
ASIT
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range0.19 | 0.20
52-Wk Range- | -
Last Close0.20
Mkt Cap (m)4.37
Dividend yield-
ISINBE0974289218
Volume62,329.00
Exchange VenueBRU

Company Profile

ASIT Biotech SA is a clinical stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform.

Key Information
Price/Earning-
Price/Book0.00
Price/Sales-
P/CF-
Rev Growth (3 year avg)0.00
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-1,366.74
Debt/Equity-

Documents

Prospectus
en 07/03/2018
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.asitbiotech.com

Financials

Income Statement
EUR201420152016201720182019
Revenue (m)0.010.000.000.000.000.00
Operating Income (m)-4.32-7.64-12.28-11.96-12.77-15.95
Net Income (m)-4.43-7.72-12.34-11.99-14.32-15.66
Basic EPS-0.52-0.91-1.10-0.94-0.86-0.77
Avg. Diluted Shares Outstanding (m)8.508.5011.2212.8116.7220.35
Balance Sheet
EUR201420152016201720182019
Current Assets (m)8.574.9713.792.459.164.10
Non Current Assets (m)0.220.511.771.842.402.71
Total Assets (m)8.785.4715.564.2911.556.81
Current Liabilities (m)1.286.332.002.654.6210.54
Total Liabilities (m)------
Total Equity (m)7.43-0.8613.131.206.47-4.18
Cash Flows
EUR201420152016201720182019
Operating Cash Flows (m)-3.38-7.61-13.70-12.84-13.02-12.97
Capital Expenditure (m)-0.18-0.37-0.38-0.16-0.37-0.10
Figures are quoted in EUR unless stated otherwise
-0.01 (-3.31%)
0.19
Last Price